National Healthcare Corp. (NHC) intrinsic value & 10-year financials

National Healthcare Corp. (NHC) has a Graham intrinsic value of $162.12 per share. At $242.82 on Oct 17, 2026, the stock trades 50% above that value. Over the last 10 fiscal years revenue grew 5.9% a year to $1.5B, with an average return on invested capital of 5.4%.

Graham intrinsic value
$162.12
Share price (Oct 17, 2026)
$242.82
Price vs Graham value
50% above
Market cap
$3.8B
Revenue (FY2025)
$1.5B
Revenue growth (10-yr CAGR)
5.9%
ROIC (10-yr avg)
5.4%
Free cash flow (FY2025)
$148.6M

NHC 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.5B $120.0M $7.67 $148.6M 8.7% 9.1%
FY2024 $1.3B $101.9M $6.53 $79.7M 6.9% 6.6%
FY2023 $1.1B $66.8M $4.34 $83.3M 5.3% 4.8%
FY2022 $1.0B $22.4M $1.45 -$21.5M 3.1% 2.6%
FY2021 $965.5M $138.6M $8.99 $23.0M 5.3% 5.4%
FY2020 $931.8M $41.9M $2.72 $181.4M 5.2% 4.4%
FY2019 $947.9M $68.2M $4.44 $73.7M 5.2% 4.5%
FY2018 $932.8M $59.0M $3.87 $68.7M 6.0% 5.8%
FY2017 $916.7M $56.2M $3.69 $62.1M 5.9% 5.4%
FY2016 $877.7M $50.5M $3.32 $28.3M 6.9% 5.0%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

NATIONAL HEALTHCARE CORP has demonstrated mature, steady growth, with revenue compounding at 5.9% annually over the past decade.

NATIONAL HEALTHCARE CORP has historically struggled to out-earn its cost of capital, averaging just 5.4% ROIC.

NATIONAL HEALTHCARE CORP has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, NATIONAL HEALTHCARE CORP is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $162.12 per share.

NHC stock: frequently asked questions

What is the intrinsic value of National Healthcare Corp. (NHC) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 8.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, NHC's intrinsic value is about $162.12 per share.

Is NHC stock undervalued?

At $242.82 (close on Oct 17, 2026), NHC trades 50% above its Graham value of $162.12. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has National Healthcare Corp. grown?

Revenue went from $877.7M in fiscal 2016 to $1.5B in fiscal 2025, a compound annual growth rate of 5.9%. Net income was $120.0M in fiscal 2025.

Does National Healthcare Corp. generate free cash flow?

National Healthcare Corp. generated $148.6M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 9 of the last 10 reported years.

What is NHC's return on invested capital?

Average ROIC over the last 10 fiscal years was 5.4%, and average return on equity was 8.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NHC data come from?

From National Healthcare Corp.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar skilled nursing care facilities stocks